Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Verigy (Nasdaq: VRGY) popped 11% in intraday trading today after the board indicated it intends to accept an offer to sell the company and back out of a separate agreement to buy a company.

So what: Last November, Verigy agreed to purchase rival LTX-Credence (Nasdaq: LTXC). Subsequently, Advantest (NYSE: ATE) offered to buy Verigy for $15 per share.

Now what: Today, Verigy's board announced the Advantest offer is "superior" and it will withdraw its recommendation in favor of acquiring LTX-Credence. This sets the stage for a legal battle, with a likely outcome that Verigy can get out of the agreement with LTX-Credence (though there may be a fee involved to quit the deal). This gives Verigy good odds of being acquired by Advantest for $15 per share, an 18% premium to Friday's close.

Interested in more info on Verigy? Add it to your watchlist by clicking here.